Biotech · Private company
LYSOGENE
Track this companyFree. Adds LYSOGENE to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- LYS-SAF302Phase 3 · Mucopolysaccharidosis Type IIIAClinicalTrials.gov · fetched Nov 12, 2026
- LYS-GM101Phase 2 · GM1 GangliosidosisClinicalTrials.gov · fetched Nov 12, 2026
- Natural historyGM1 GangliosidosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Safety and Efficacy Study of LYS-GM101 Gene Therapy in Patients With GM1 GangliosidosisPHASE1_PHASE2 · TERMINATED · started May 11, 2021ClinicalTrials.gov NCT04273269 · fetched Nov 12, 2026
- Interviews and Video Capture in Patients With GM1 GangliosidosisCOMPLETED · started Apr 20, 2020ClinicalTrials.gov NCT04310163 · fetched Nov 12, 2026
- Study of AAVrh10-h.SGSH Gene Therapy in Patients With Mucopolysaccharidosis Type IIIA (MPS IIIA)PHASE2_PHASE3 · UNKNOWN · started Dec 17, 2018ClinicalTrials.gov NCT03612869 · fetched Nov 12, 2026